EU and US could reach trade deal this weekend - Reuters
On Monday, RBC Capital Markets adjusted their outlook on Nutrien shares (NYSE:NTR), raising the price target to $65 from the previous $60, while keeping an Outperform rating on the stock. The revision reflects the firm’s confidence in Nutrien’s operational execution and favorable agricultural and fertilizer market conditions. With a market capitalization of $26.8 billion, Nutrien has maintained its position as a prominent player in the chemicals industry. According to InvestingPro data, 12 analysts have recently revised their earnings expectations upward for the upcoming period.
Analysts at RBC Capital highlighted Nutrien’s effective strategies, noting the company is on track to meet its 2026 goals for the Retail segment, achieve cost savings ahead of schedule, and optimize capital expenditure. The firm anticipates Nutrien will generate robust cash flows, estimating around $2 billion annually, which equates to approximately an 8% yield. This strong cash position is expected to support Nutrien’s substantial dividend, consistent share buybacks, and strategic acquisitions in the Retail sector. InvestingPro data reveals the company has raised its dividend for seven consecutive years, currently offering a 3.92% yield, while management has been actively buying back shares.
The RBC Capital analyst, Andrew Wong, expressed a positive outlook on Nutrien’s performance, stating that the company is navigating well through a supportive agricultural and fertilizer environment. Wong believes that the market’s unfavorable reaction to Nutrien’s first-quarter earnings miss was unwarranted. He maintains a bullish stance on the company, considering it a solid defensive play in the agricultural sector with robust fundamentals, even as broader economic and trade uncertainties persist. With an overall Financial Health score of "FAIR" from InvestingPro, the company shows particular strength in price momentum and profitability metrics, though current trading levels suggest slight overvaluation relative to Fair Value estimates.
Nutrien’s commitment to achieving its long-term targets, coupled with its efficient capital spending and cost-saving measures, positions the company favorably in the eyes of RBC Capital analysts. The firm’s raised price target is a testament to their belief in Nutrien’s ability to continue delivering value to shareholders amidst a positive backdrop for the agriculture and fertilizer industries. The company maintains a healthy current ratio of 1.22 and has demonstrated steady revenue growth with a 5-year CAGR of 5%.
In other recent news, Nutrien Ltd. reported first-quarter earnings that fell short of analyst expectations. The company posted adjusted earnings per share of $0.11, significantly below the consensus estimate of $0.36. Nutrien’s revenue was $5.1 billion, missing expectations of $5.2 billion. The adjusted EBITDA for the quarter declined 19% year-over-year to $852 million, primarily due to lower potash prices in North America and weaker retail earnings. Weather-related delays also impacted sales and margins in the U.S. and Australia retail segments. Despite these challenges, Nutrien maintained its full-year 2025 guidance, forecasting retail adjusted EBITDA between $1.65 billion and $1.85 billion and potash sales volumes of 13.6 million to 14.4 million tonnes. The company also repurchased 3.6 million shares for $188 million in 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.